Trump’s Pick for HHS Tells Senate Drug Prices are Too High

Drug Industry Daily
A A
President Trump’s nominee for the next secretary of HHS, former Eli Lilly executive Alex Azar, told the Senate’s health committee Wednesday he agrees prescription drug prices are too high, and would welcome congressional action if appointed to the post.

To View This Article:

Login

Subscribe To Drug Industry Daily